Yeast-derived Glycoprotein B-1 of Herpes Simplex Virus (HSV) as a Candidate for an HSV Vaccine

  • Yoichiro Kino
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 278)


Although antiherpes drugs such as acyclovir or Ara-A are available, herpes simplex virus (HSV) infections are still a serious clinical problem. Under the circumstances, as a method of prophylaxis, vaccine development seems to be very important. As candidates for HSV vaccines, deletion-mutant live attenuated vaccines (1) and subunit vaccines consisting of viral glycoproteins (2, 3) have been extensively investigated.


Herpes Simplex Virus Rhesus Monkey Trigeminal Ganglion Subunit Vaccine Recurrent Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Meignier, B., Longnecker, R. and Roizman, B. (1988) J. Infect. Dis. 158, 602–614.PubMedCrossRefGoogle Scholar
  2. 2.
    Cappel, R., Sprecher, S., De Cuyper, F. and De Braekeleer, J. (1985) J. Mecs Virol. 16, 137–145.CrossRefGoogle Scholar
  3. 3.
    Buchan, A., Skinner, G. R. B., Fuller, A., Hartley, C., Hallworth, J., Stocker, D., Melling, J. and Wiblin, C. (1985) Vaccine 3, 49–53.PubMedCrossRefGoogle Scholar
  4. 4.
    Kino, Y., Eto, T., Nishiyama, K, Ohtomo, N. and Mori, R. (1985) Arch. ViroL 89, 69–80.CrossRefGoogle Scholar
  5. 5.
    Nozaki, C., Makizumi, L., Kino, Y., Nakatake, H., Eto, T., Mizuno, K., Hamada, F., and Ohtomo, N. (1985) Virus Res. 4, 107–113.PubMedCrossRefGoogle Scholar
  6. 6.
    Stanberry, L. R., Kern, E. R., Abbott, T. M. and Overall, J. C., Jr. (1982) J. Infect. Dis. 157, 156–163.CrossRefGoogle Scholar
  7. 7.
    Meignier, B., Norrild, B., Thuning, C., Warren, J., Frenkel, N., Nahmias, A. J., Rapp, F. and Roizman, B. (1986) Int. J. Cancer 38, 387–394.PubMedCrossRefGoogle Scholar
  8. 8.
    Dix, R. D. and Mill, J. (1985) J. Med ViroL 17, 9–18.PubMedCrossRefGoogle Scholar
  9. 9.
    Berman, P. W., Gregory, T., Crase, D. and Lasky, L. A. (1984) Science (Washington, D.C., 1883-) 227, 1490–1492.CrossRefGoogle Scholar
  10. 10.
    Burke, R. L., Van Nest, G., Carlson, J., Gervase, B., Goldbeck, C., Ng, P., Sanchez-Pescador, L., Stanberry, L. R. and Ott, G. (1989) in Vaccines 89 ( Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. ), pp. 377–382.Google Scholar
  11. 11.
    Meignier, B., Jourdier, T. M., Norrild, B., Pereira, L. and Roizman, B. (1987) J. Infect. Dis. 155921–930.Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Yoichiro Kino
    • 1
  1. 1.Chemo-Sero-Therapeutic Research InstituteKumamoto 860Japan

Personalised recommendations